ROCKET PHARMACEUTICALS, INC. — Director's Dealing 2017

Jun 21, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: INOTEK PHARMACEUTICALS CORP (ITEK)
CIK: 0001281895
Period of Report: 2017-06-20

Reporting Person: HOWES PAUL G (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-06-20	Stock Options (Right to Buy)	$1.80	A	45000	Acquired	2027-06-19	Common Stock (45000)	Direct

Footnotes

F1: The stock option award was issued pursuant to Inotek Pharmaceuticals Corporation's 2014 Stock Option and Incentive Plan. The option grant shall vest in equal quarterly installments at the end of each quarter following June 20, 2017, subject to continued service through such dates.